Skip to content
naulon
Get started

No retraction, correction or concern found when last checked on Oct 26, 2026.

Streptococcus suis – The “Two Faces” of a Pathobiont in the Porcine Respiratory Tract

Désirée Vötsch, Maren Willenborg, Yenehiwot B. Weldearegay and 1 more

Frontiers in Microbiology · 2018 · Review

doi:10.3389/fmicb.2018.00480

Abstract

Streptococcus (S.) suis is a frequent early colonizer of the upper respiratory tract of pigs. In fact, it is difficult to find S. suis free animals under natural conditions, showing the successful adaptation of this pathogen to its porcine reservoir host. On the other hand, S. suis can cause life-threatening diseases and represents the most important bacterial cause of meningitis in pigs worldwide. Notably, S. suis can also cause zoonotic infections, such as meningitis, septicemia, endocarditis and other diseases in humans. In Asia, it is classified as an emerging zoonotic pathogen and currently considered as one of the most important causes of bacterial meningitis in adults. The “two faces” of S. suis, one of a colonizing microbe and the other of a highly invasive pathogen, have raised many questions concerning the interpretation of diagnostic detection and the definition of virulence. Thus, one major research challenge is the identification of virulence-markers which allow differentiation of commensal and virulent strains. This is complicated by the high phenotypic and genotypic diversity of S. suis, as reflected by the occurrence of (at least) 33 capsular serotypes. In this review, we present current knowledge in the context of S. suis as a highly diverse pathobiont in the porcine respiratory tract that can exploit disrupted host homeostasis to flourish and promote inflammatory processes and invasive diseases in pigs and humans.

Full text

From PubMed Central, U.S. National Library of Medicine, as current on Oct 26, 2026. Paragraph numbers are ours, so an answer can point at one.

Introduction

Streptococcus (S.) suis is a commensal part of the respiratory microbiota of pigs, in particular of the tonsils and nasal cavities, but it can also cause highly invasive infections, such as meningitis, arthritis, endocarditis, bronchopneumonia, as well as septicemia and sudden death. Notably, though the colonization rate is up to 100%, clinical cases of S. suis infections, associated with meningitis, septicemia, or pneumonia, are by far less frequently reported. S. suis is also considered an emerging zoonotic agent which can cause meningitis and sepsis in humans. In contrast to swine, humans seem to be rarely colonized by S. suis. However, this remains to be studied in more detail and, therefore, human carrier rates (reported to be approximately 5% on average worldwide with respect to people in contact with pigs or pig products) may be underestimated.

Streptococcus suis infections are known to be multi-factorial, unfavorable environmental conditions facilitate the development of disease. The nasopharynx is a reservoir niche for S. suis and various other (potentially) pathogenic microorganisms and commensals. In this niche commensals can act as innocent bystander microbes, which inherently colonize the respiratory mucosa and can support other facultative pathogens to induce clinical disease. Those facultative pathogenic organisms are known as pathobionts. If pathogens play a dominant role in population changes of the microbiota and additionally manipulate the host response they are so-called keystone pathogens which can enhance the virulence of pathobionts leading to dysbiosis and inflammatory disease. For S. suis, synergistic activities with other bacterial agents, such as Pasteurella multocida or Mycoplasma hyopneumoniae, as well as respiratory viruses like porcine reproductive and respiratory syndrome virus (PRRSV), porcine circovirus type 2, and swine influenza virus (SIV) may increase the risk of invasive infections. SIV and PRRVS are well-known keystone pathogens, since they pave the way for S. suis infections leading to severe respiratory symptoms and serious pneumonia.

Nevertheless, interactions of S. suis with the mucosal immune system and evasion of innate immune defense mechanisms are crucial for induction of disease. S. suis has several immune evasion strategies, for example, expression of polysaccharide capsule (CPS) to prevent phagocytosis-dependent killing mechanisms, or biofilm formation which may protect S. suis from antimicrobials. Such features seem to play a role in virulence but may also be important for survival as a pathobiont. In this review, we focus on the role of S. suis as a typical respiratory pathobiont in swine, which possesses a highly invasive potential and causes severe infectious diseases in pigs and humans. In particular, we address the epidemiology of S. suis in pigs and humans, its diversity, and its two “faces” as a commensal and invasive pathogen (illustrated in Figure 1). Finally, we also include possible models to study host–pathobiont interactions in the respiratory tract. Since a number of excellent reviews on virulence mechanisms and virulence-associated factors have been published in recent years, we will include such mechanisms and factors only with respect to their potential role for the lifestyle of S. suis as a pathobiont.

Epidemiology of S. suis in Pigs and Humans

Streptococcus suis is a widely distributed pathobiont and an emerging zoonotic pathogen. Its natural reservoir hosts are pigs and wild boars. Subclinical infected pigs play an important role in the epidemiology of S. suis as the main source of infection for other pigs and humans. Susceptible pigs (especially weaning piglets) can suffer from meningitis, septicemia, pneumonia, endocarditis, or polyarthritis. Horizontal transmission via the respiratory tract due to nose-to-nose contact is the predominant route, but vertical transmission from an infected sow to piglets via the genital tract during farrowing can also occur.

Humans can get infected with S. suis by eating raw or undercooked pork products or via cutaneous lesions when they get in contact with infected pigs or contaminated pork products. People in Asia are particularly affected because high-risk dishes, e.g., raw blood pudding, “tiet canh”, are common and the pig industry is more and more increasing while people are not aware of the risks of infection. In Western countries only sporadic cases of human infections occur due to contact to infected pigs or raw pork meat. In humans, S. suis causes mainly meningitis and septicemia [including streptococcal toxic shock-like syndrome/STSLS], but cases of pneumonia, endocarditis, or peritonitis have also been reported. Some studies suggest that humans can also be healthy carriers of S. suis. Until end of December 2013 a total of 1642 human cases have been reported worldwide, but this number has increased since then due to a high number of recent case reports and the high likelihood of misdiagnosis. Most of the human cases occurred in Asia (>90%), especially in Vietnam, Thailand, and China. During the two outbreaks in China in 1998 and 2005, a total of 240 human cases were described.

Furthermore, S. suis can be found in the environment of slaughterhouses and wet markets, particularly in Southeast Asia, which constitutes another source of infection for humans. In addition, S. suis was isolated from other animal species, such as rabbits, lambs, and dogs, though some of those had no close contact to pigs. These sources of infection should also be considered as a potential risk, especially since a few cases of human infections have been reported without any prior contact to pigs or pork products.

Diversity of S. suis

Streptococcus suis is, genetically and phenotypically, a heterogeneous bacterial species. Strains belonging to different capsular serotypes or even to the same serotype differ from each other genetically. For a comprehensive recent overview on the distribution of S. suis serotypes and genotypes, the reader is referred to a recent review by.

Multilocus sequence typing (MLST) is a method for genetic characterization, which allows to evaluate the epidemiology, the relation between different strains and virulent properties in more detail. have established a model of MLST for S. suis using seven different house-keeping genes (cpn60, dpr, recA, aroA, thrA, gki, and mutS). The nucleotide sequences of several alleles can be associated with each gene and the combination of those alleles of each isolate defines the sequence type (ST). Isolates with the same ST belong to the same clone. Occasionally, the same ST can comprise isolates with different serotypes and isolates with the same serotype could belong to different ST. In general, ST1 is mostly associated with clinical cases in both, pigs and humans, in Europe, Asia, and Argentina. ST7, which is responsible for the two large outbreaks in China in 1998 and 2005, seems to be endemic in China and Hong Kong. In North America, most of the isolated and analyzed serotype 2 strains from pigs and humans belong to ST25 and ST28, the latter one has also been reported in Japan and other countries. ST101 to 104 is endemic in Thailand, whereas ST20 was found only in humans in Europe [The Netherlands and France].

So far, 35 serotypes based on the antigenicity of the capsular polysaccharides are known, but some of them have been suggested to belong to different bacterial species. developed a PCR which is able to detect all 35 serotypes but cannot distinguish serotypes 2 and 14 from serotypes 1/2 and 1, respectively. Especially these serotypes are commonly isolated from pigs. Additionally, there are many nontypable isolates, which do not agglutinate with any of the typing antisera and which either belong to unknown encapsulated serotypes or non-encapsulated strains. As reviewed recently by the worldwide predominant serotype from diseased pigs is serotype 2 (27.9%), followed by serotypes 9 (19.4%) and 3 (15.9%). A total of 15.5% of the isolates were nontypable by serotyping. The serotype distribution is different in healthy pigs, from which serotype 2 is less frequently isolated. Unfortunately, there exist only few epidemiological data on S. suis in diseased pigs from those countries where most human cases are reported. In some European countries, serotype 9 was more frequently found in diseased pigs and wild boars than serotype 2, but until now no human serotype 9 cases have been reported. A recent study from Thailand revealed serotype 23 being the most prevalent in healthy pigs in Phayao Province, followed by serotypes 9, 7, and 2. Thirty-seven percent of the isolates was nontypable by multiplex PCR. Another study from Northern Thailand (Chiang Mai Province) found mostly serotype 3 isolates in submaxillary glands of pig carcasses sold in wet markets. A further study investigated samples from asymptomatic pigs from central Thailand and found mainly serotype 16 strains. Taken together, S. suis serotype distribution differs worldwide, within a country, and even within the same region. Moreover, it was shown that pigs can be colonized by different serotypes at the same time. This raises the question whether the disease of a given animal is caused by a strain of a certain serotype or by interactions of several strains of different serotypes. Furthermore, it is unclear why some pigs in a herd get infected by a certain serotype while others do not.

Worldwide, human cases are reported to be mainly due to serotype 2 (74.7%) and 14 (2.0%), both serotypes are equally involved in cases of meningitis (50–70%) and septicemia (20–25%). Only occasional cases were reported to be caused by serotypes 4, 5, 16, 21, 24, and 31. Most of the persons, who were infected by serotypes other than serotype 2, were suffering from a pre-existing liver cirrhosis or other immunocompromising illnesses. This suggests that those serotypes may be less virulent than serotype 2 strains. reported that S. suis isolated from human cases in Argentina between 1995 and 2016 from cases of meningitis were caused by serotype 2 strains, except for one case caused by a serotype 5 isolate. This is interesting because only few human cases have been reported from South America so far. One case of meningitis due to S. suis serotype 2 from Togo was reported in 2016, which illustrates the emergence of this pathogen in a country, where it was previously unrecognized.

Although human cases occur only sporadically in Europe, the reported cases count for 8.5% of all human cases worldwide. This may be explained by the fact that most of the European countries have a highly developed pig industry and the virulent serotype 2 can be found frequently in diseased pigs. In North America, only a few cases of human infections have been reported, although this country has the highest number of reports from diseased pigs. One possible explanation may be that serotype 2 strains from North America are less virulent than Eurasian strains.

The Commensal “Face” of S. suis

Although the survival mechanism of S. suis as a pathobiont remains to be elucidated, it seems clear that the S. suis genome of approximately 2 Mbp encodes for a variety of enzymes, putative adhesins, and other factors, which enable it to colonize the host with other commensals (and pathogens). Here, we focus on bacterial factors and mechanisms, which most likely are important for the commensal life of S. suis in the respiratory tract, though these factors may also contribute to virulence (Figure 1, upper part).

The innate and adaptive immune mechanisms in the respiratory tract play a major role in pathogen recognition, processing, and elimination thereby maintaining tissue homeostasis. Mucociliary activity of ciliated epithelial cells is a major defense barrier encountered by microbes entering the host via the respiratory tract. However, some pathogens, including S. suis, have adapted to colonize the respiratory cilia. Thus, the initial step in colonization, bacterial adherence, is crucial for development of a carrier state. First studies on adhesins of S. suis were published in the early 1990s. In recent years, we learnt much more about mechanisms of adherence and tissue tropisms of S. suis, though we still do not know precisely what adhesins are essential for infection.

Salivary glycoproteins in humans have terminal sialic acids, which are reported to serve as glycan receptor motifs. These motifs are commonly recognized by commensal streptococcal bacteria such as, e.g., Streptococcus gordonii. A recent study by revealed that S. suis serotype 2 and 9 strains express genes coding for multimodal adhesion proteins known as antigen I/II (AgI/II). In the presence of salivary glycoproteins, AgI/II leads to the aggregation of S. suis, adherence, and colonization of the upper respiratory tract of pigs. Especially in serotype 9, the AgI/II is reported to facilitate aggregation and biofilm formation, and these aggregated bacteria could be swallowed, but are protected from the low pH in the stomach, which may enhance colonization of the intestine. S. suis also has an adhesin known as factor H-binding protein, Fhb. Factor H is an abundant host protein in the plasma, which is responsible in protecting the host from excessive complement effects and maintains complement homeostasis [reviewed in ]. Binding of S. suis to factor H by Fhb results in enhanced adherence of the bacteria to epithelial and endothelial cells. Fhb also protects S. suis from phagocytosis and complement mediated killing. reported the structural domains involved in binding of Fhb to the host cell receptor glycolipid GbO3, which is abundantly expressed on endothelial cells and certain epithelial cells. For further details on S. suis adhesins involved in adhesion to epithelial cells, the reader is referred to a recent comprehensive review on initial steps of S. suis pathogenesis.

The most prominent structure of S. suis is the polysaccharide capsule, of which several different antigen types exist, as described above. Most likely, the capsule covers adherence-mediating surface components, but it does not completely inhibit adherence to host cells. Accordingly, some studies showed that the absence (or downregulation) of the capsule increases the exposure of adhesins and subsequent bacterial adherence. The thickness of the capsule depends on the bacterial environment in its host niche. It has been reported that the capsule is thinner during colonization and invasion of the respiratory epithelium, possibly to expose adhesins for better attachment to the epithelial cells. also reported that the capsule hinders adhesins and hydrophobic components of S. suis, which are responsible for biofilm formation. However, in the bloodstream, the thickness of the capsule is higher and this enables S. suis to escape phagocytosis. This underlines that the expression of the capsule needs to be controlled during colonization (and subsequent infection).

The expression of genes responsible for S. suis capsule synthesis is regulated by transcriptional regulators such as catabolite control protein A (CcpA) and small RNAs (sRNAs) like sRNA rss04. According to depletion of ccpA gene in S. suis resulted in a phenotype similar to a non-encapsulated strain, whereas the ccpA mutant showed reduced capsule thickness and higher susceptibility to phagocytosis compared to the wild-type (WT) parental strain. In contrast, the sRNA rss04 has an opposite effect. Transmission electron microscopic analysis revealed that S. suis Δrss04 had a thicker capsule compared to the WT and complemented strains and, therefore, its presence appears to repress CPS production by downregulating the expression of ccpA. Thus, most likely capsule synthesis and its coordinated regulation are very important for the colonization and survival of S. suis as a pathobiont.

Some microorganisms escape hostile environments by aggregation in the form of biofilms that enable them to persist and colonize tissues, resist clearance from host defense mechanisms and antimicrobials, and facilitate exchange of genetic information. S. suis is able to form biofilms which is controlled by quorum sensing. This is a signaling network regulated by luxS gene (coding for the enzyme S-ribosylhomocysteinase, LuxS), which has been found in virulent S. suis serotype 2 strains. It has been reported that LuxS plays an important role by its ability to enhance the biosynthesis of auto-inducer 2 (AI-2), adherence, biofilm formation, cell metabolism, and resistance to host immune responses and antimicrobial therapy. Biofilm production by S. suis is induced via the activity of fibrinogen-mediated cross bridging of S. suis. The presence of fibrinogen could stimulate the expression of adhesins thereby facilitating adherence of the bacteria to each other. Moreover, mucin, produced by goblet cells, may enhance biofilm formation and promote survival in nutrient-limited condition as reported for Streptococcus mutans. Bacteria forming biofilms resist antimicrobials better than planktonic cells. It has been reported that virulent strains of S. suis have a higher ability to produce biofilms than avirulent strains. The same authors reported that the adherence of S. suis forming a biofilm to human pharyngeal epithelial (HEp-2) cells was lower than that of planktonic cells suggesting a reduced virulence of S. suis in the former stage. On the one hand, in biofilms bacterial metabolism and expression of virulence-associated genes is reduced; on the other hand, secreted toxins may be trapped in the polysaccharide matrix resulting in less tissue damage to the host. This may explain why virulent strains of S. suis can also be harmless components of the respiratory microbiome.

The Pathogenic “Face” of S. suis

As a facultative pathogenic bacterium, S. suis causes infectious diseases that are considered to be multifactorial, i.e., whether an initial infection remains subclinical or leads to clinical infection depends on several factors. It is long known that unfavorable environmental conditions such as overcrowding, poor ventilation and climatic conditions, poor hygiene status, high air pollution load, and other stressors correlate with an increasing clinical disease rate in pigs. Furthermore, host-specific factors, such as age, genetic background, and immunosuppression, influence disease development. Weaning piglets are most susceptible since protective maternal antibodies decline. Besides, pigs suffering from other bacterial and/or viral infections of the upper respiratory tract are more susceptible. In humans, especially advanced age and presence of pre-existing medical conditions that suppress the immune system are common predisposing factors for clinical S. suis infections.

When (colonizing) S. suis encounters conditions that favor its replication, invasion, and evasion of immune control mechanisms, the opportunistic pathogen becomes pathogenic. This transition seems to depend on the individual strain and its equipment with virulence-(associated) factors, since only certain strains, geno-, and serotypes are isolated from diseased animals. In addition to the presence of virulence-related genes, their coordinated expression during infection is crucial for pathogenicity. Thus, host-, environment-, and pathogen-dependent factors are drivers of pathogenicity (Figure 1).

The respiratory tract can easily be colonized by environmental microorganisms which get access via direct contact or by aerosols. Thus, the upper airway tract harbors a complex and dynamic population of bacterial species including, e.g., Haemophilus parasuis, M. hyopneumoniae, Actinobacillus pleuropneumoniae, Actinobacillus suis, P. multocida, Bordetella bronchiseptica, and S. suis, as well as viruses like PRRSV, porcine circovirus type 2, and SIV. Accordingly, porcine respiratory disease is often referred to as porcine respiratory disease complex due to its polymicrobial nature.

The members of the respiratory microbiota differ in their intrinsic pathogenic potential and their role in shaping the population structure thereby building a mixture of non-pathogenic (accessory) commensal bacteria, which act as innocent bystander microbes or support pathogenic bacteria, and facultative pathogens known as pathobionts, such as S. suis. Moreover, keystone pathogens, sometimes also named master manipulators, play a dominant role in population changes, which may lead to subversion of the host immune system. This can affect the composition of the microbiota resulting in dysbiosis and increase of virulence of pathobionts, which then exploit the disrupted homeostasis for their invasion into deeper tissues. For S. suis, PRRSV is considered to act as a keystone pathogen since PRRSV and S. suis coinfections in pig herds are frequently found and co-infection of S. suis with PRRSV have been reported to enhance morbidity of S. suis infections. Although the precise mechanism by which PRRSV predisposes pigs to S. suis infection is unknown, recent studies showed that an altered innate immune system and exacerbating inflammatory responses are responsible for increasing the risk of S. suis infection in PRRSV-co-infected pigs. In vitro studies support the assumption that a decreased phagocytic activity by PRRSV-infected dendritic cells and porcine pulmonary macrophages may lead to a higher susceptibility to a subsequent S. suis infection. Furthermore, an epidemiological association between PRRSV in pigs and S. suis infections in pigs and humans was described. To the best of our knowledge, there are no reports on associations of human viral respiratory infections with human S. suis infections.

Likewise, S. suis seems to be a pathobiont for infection by SIV. Experimental co-infections of pigs with SIV-S. suis revealed more severe clinical symptoms as well as more serious pathological changes and apoptosis of lungs compared to pigs mono-infected with either S. suis or SIV. Although very little is known about interactions between viral and bacterial pathogens and their role in the co-pathogenesis of respective diseases, in general virus-induced damage of the mucociliary barrier and a decreased immune response are considered to predispose pigs to secondary infections and pneumonia by opportunistic bacterial pathobionts. found that SIV-facilitated adherence, colonization, and invasion of S. suis in a porcine precision-cut lung slices (PCLS) co-infection model was mediated by virus-induced impairment of the ciliary activity. Similarly, enhanced adherence of S. suis and direct binding in a capsule-dependent manner of S. suis to SIV- or SIV-infected cells were also found in co-infected newborn pig tracheal cells. Thus, binding of S. suis to SIV-pre-infected cells appears to enable the bacterium to switch to an invasive pathogen. A further feature of SIV-S. suis co-infections seems to be an increased inflammatory response due to upregulation of inflammatory mediators like chemokines, interleukins, cell adhesion molecules, and eicosanoids, as it has been found in in vitro and in vivo experiments. On the other hand, S. suis can also affect SIV infection. found increased viral loads in nasal swabs and lungs in co-infected pigs. Likewise, infection ability of SIV was enhanced after treatment with S. suis culture supernatants in vitro, most likely due to the proteolytic activity of a S. suis protease. In contrast, observed a negative effect on the growth capacity of SIV in S. suis co-infected cells.

Nevertheless, interactions of different microorganisms in the respiratory tract and their contribution to co-pathogenesis remain unclear. As suggested by the modes of actions of pathogens could be either additive or synergistic. Metatranscriptomic and metabolomic studies and appropriate infection models will surely help for better understanding of bacterial interactions and their roles in causing diseases or carrier states.

In Vitro Models to Study Host–Pathobiont Interactions in the Respiratory Tract

As outlined above, we are just beginning to understand the interplay of commensals, pathobionts, and keystone pathogens in the respiratory tract. Studies to dissect these complex processes should be carried out in respective animal models, e.g., in pigs, or under conditions which most closely mimic in vivo conditions. Since animal experiments have limitations for several reasons, ex vivo/in vitro tissue cell culture models receive more and more attention. Two of such models based on primary porcine respiratory epithelial cells are air–liquid-interface (ALI) cultures and PCLS. Both have been shown to be suitable to study host–pathobiont interactions of S. suis in the porcine respiratory tract.

For ALI cultures, primary porcine tracheal and bronchial epithelial cells (PTEC and PBEC) are isolated from swine lungs and cultured in a transwell system at ALI conditions for 4–5 weeks until the cells are well differentiated. Those well-differentiated respiratory epithelial cells build a pseudostratified epithelium, containing ciliated and mucin-producing cells (Figure 2A), and, therefore, represent the in vivo situation in the porcine respiratory tract. The expression of tight junction proteins and the development of a high trans-epithelial resistance indicate an epithelial barrier function. Human ALI culture systems have been proved suitable for modeling the respiratory tract by transcriptome analyses and showing physiological responses to different pathogens. This cell culture model is particularly suitable to study the adherence and invasion of bacteria such as S. suis to well-differentiated respiratory epithelial cells and its effect on the epithelial barrier in vitro.

The advantage of the ex vivo PCLS model is that it preserves the structural and functional integrity of the lung, including the ciliary activity at the bronchiolar surface (Figure 2B), since those slices are pieces of lung tissue which can be kept in cell culture medium for several days. PCLS have been proved to be convincing alternatives to in vivo experiments for physiological, pharmacological, and toxicological investigations. This method allows to investigate the adherence, colonization, and invasion of bacteria like S. suis and to study microbial effects on bronchial epithelial cells, e.g., the ciliary motility and bronchus-constriction, by light microscopy. A limitation of PCLS is the restricted time of viability of the cells, making it less suitable for studying long-term effects.

Air–liquid-interface cultures and PCLS as well as further models, such as organoids from the respiratory tract, will have to be further improved, e.g., by including immune cells. Such models and respective imaging techniques will enable researchers in the future to dissect the complex interactions of microbes on mucosal surfaces with each other and the host, which will contribute to a better understanding of the role that pathobionts play in infection processes in the airway system.

Author Contributions

PV-W developed the concept of the manuscript. DV, MW, YW, and PV-W wrote the manuscript.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References 139

  1. 1.

    Amass S. F. SanMiguel P. Clark L. K. (1997 ). Demonstration of vertical transmission of Streptococcus suis in swine by genomic fingerprinting. J. Clin. Microbiol. 35 1595–1596.

    Not in our library10.1128/jcm.35.6.1595-1596.1997

  2. 2.

    Arends J. P. Hartwig N. Rudolphy M. Zanen H. C. (1984 ). Carrier rate of Streptococcus suis capsular type 2 in palatine tonsils of slaughtered pigs. J. Clin. Microbiol. 20 945–947.

    Not in our library10.1128/jcm.20.5.945-947.1984

  3. 3.

    Arends J. P. Zanen H. C. (1988 ). Meningitis caused by Streptococcus suis in humans. Rev. Infect. Dis. 10 131–137.

    Not in our library10.1093/clinids/10.1.131

  4. 4.

    Auray G. Lachance C. Wang Y. Gagnon C. A. Segura M. Gottschalk M. (2016 ). Transcriptional analysis of PRRSV-infected porcine dendritic cell response to Streptococcus suis infection reveals up-regulation of inflammatory-related genes expression. PLoS One 11:e0156019.

    Not in our library10.1371/journal.pone.0156019

  5. 5.

    Baums C. G. Verkuhlen G. J. Rehm T. Silva L. M. Beyerbach M. Pohlmeyer K. (2007 ). Prevalence of Streptococcus suis genotypes in wild boars of Northwestern Germany. Appl. Environ. Microbiol. 73 711–717.

    Not in our library10.1128/aem.01800-06

  6. 6.

    Benga L. Goethe R. Rohde M. Valentin-Weigand P. (2004 ). Non-encapsulated strains reveal novel insights in invasion and survival of Streptococcus suis in epithelial cells. Cell Microbiol. 6 867–881.

    Not in our library10.1111/j.1462-5822.2004.00409.x

  7. 7.

    Blume V. Luque I. Vela A. I. Borge C. Maldonado A. Dominguez L. (2009 ). Genetic and virulence-phenotype characterization of serotypes 2 and 9 of Streptococcus suis swine isolates. Int. Microbiol. 12 161–166.

    Not in our library

  8. 8.

    Bojarska A. Molska E. Janas K. Skoczynska A. Stefaniuk E. Hryniewicz W. (2016 ). Streptococcus suis in invasive human infections in Poland: clonality and determinants of virulence and antimicrobial resistance. Eur. J. Clin. Microbiol. Infect. Dis. 35 917–925.

    Not in our library10.1007/s10096-016-2616-x

  9. 9.

    Bonifait L. Grignon L. Grenier D. (2008 ). Fibrinogen induces biofilm formation by Streptococcus suis and enhances its antibiotic resistance. Appl. Environ. Microbiol. 74 4969–4972.

    Not in our library10.1128/aem.00558-08

  10. 10.

    Brassard J. Gottschalk M. Quessy S. (2004 ). Cloning and purification of the Streptococcus suis serotype 2 glyceraldehyde-3-phosphate dehydrogenase and its involvement as an adhesin. Vet. Microbiol. 102 87–94.

    Not in our library10.1016/j.vetmic.2004.05.008

  11. 11.

    Callejo R. Prieto M. Salamone F. Auger J. P. Goyette-Desjardins G. Gottschalk M. (2014 ). Atypical Streptococcus suis in man, Argentina, 2013. Emerg. Infect. Dis. 20 500–502.

    Not in our library10.3201/eid2003.131148

  12. 12.

    Callejo R. Zheng H. Du P. Prieto M. Xu J. Zielinski G. (2016 ). Streptococcus suis serotype 2 strains isolated in Argentina (South America) are different from those recovered in North America and present a higher risk for humans. JMM Case Rep. 3:e005066.

    Not in our library10.1099/jmmcr.0.005066

  13. 13.

    Chabot-Roy G. Willson P. Segura M. Lacouture S. Gottschalk M. (2006 ). Phagocytosis and killing of Streptococcus suis by porcine neutrophils. Microb. Pathog. 41 21–32.

    Not in our library10.1016/j.micpath.2006.04.001

  14. 14.

    Chang B. Wada A. Ikebe T. Ohnishi M. Mita K. Endo M. (2006 ). Characteristics of Streptococcus suis isolated from patients in Japan. Jpn. J. Infect. Dis. 59 397–399.

    Not in our library

  15. 15.

    Chanter N. Jones P. W. Alexander T. J. (1993 ). Meningitis in pigs caused by Streptococcus suis–a speculative review. Vet. Microbiol. 36 39–55.

    Not in our library10.1016/0378-1135(93)90127-s

  16. 16.

    Chuzeville S. Auger J. P. Dumesnil A. Roy D. Lacouture S. Fittipaldi N. (2017 ). Serotype-specific role of antigen I/II in the initial steps of the pathogenesis of the infection caused by Streptococcus suis. Vet. Res. 48:39.

    Not in our library10.1186/s13567-017-0443-4

  17. 17.

    Clifton-Hadley F. A. Alexander T. J. (1980 ). The carrier site and carrier rate of Streptococcus suis type II in pigs. Vet. Rec. 107 40–41.

    Not in our library10.1136/vr.107.2.40

  18. 18.

    Cloutier G. D’Allaire S. Martinez G. Surprenant C. Lacouture S. Gottschalk M. (2003 ). Epidemiology of Streptococcus suis serotype 5 infection in a pig herd with and without clinical disease. Vet. Microbiol. 97 135–151.

    Not in our library10.1016/j.vetmic.2003.09.018

  19. 19.

    Dang Y. Lachance C. Wang Y. Gagnon C. A. Savard C. Segura M. (2014 ). Transcriptional approach to study porcine tracheal epithelial cells individually or dually infected with swine influenza virus and Streptococcus suis. BMC Vet. Res. 10:86.

    Not in our library10.1186/1746-6148-10-86

  20. 20.

    de Cordoba S. R. de Jorge E. G. (2008 ). Translational mini-review series on complement factor H: genetics and disease associations of human complement factor H. Clin. Exp. Immunol. 151 1–13.

    Not in our library10.1111/j.1365-2249.2007.03552.x

  21. 21.

    Dekker N. Bouma A. Daemen I. Klinkenberg D. van Leengoed L. Wagenaar J. A. (2013 ). Effect of spatial separation of pigs on spread of Streptococcus suis serotype 9. PLoS One 8:e61339.

    Not in our library10.1371/journal.pone.0061339

  22. 22.

    Deng L. Bensing B. A. Thamadilok S. Yu H. Lau K. Chen X. (2014 ). Oral streptococci utilize a Siglec-like domain of serine-rich repeat adhesins to preferentially target platelet sialoglycans in human blood. PLoS Pathog. 10:e1004540.

    Not in our library10.1371/journal.ppat.1004540

  23. 23.

    Donlan R. M. Costerton J. W. (2002 ). Biofilms: survival mechanisms of clinically relevant microorganisms. Clin. Microbiol. Rev. 15 167–193.

    Not in our library10.1128/cmr.15.2.167-193.2002

  24. 24.

    Dvorak A. Tilley A. E. Shaykhiev R. Wang R. Crystal R. G. (2011 ). Do airway epithelium air-liquid cultures represent the in vivo airway epithelium transcriptome? Am. J. Respir. Cell Mol. Biol. 44 465–473.

    Not in our library10.1165/rcmb.2009-0453oc

  25. 25.

    Elbers A. R. Vecht U. Osterhaus A. D. Groen J. Wisselink H. J. Diepersloot R. J. (1999 ). Low prevalence of antibodies against the zoonotic agents Brucella abortus, Leptospira spp., Streptococcus suis serotype II, hantavirus, and lymphocytic choriomeningitis virus among veterinarians and pig farmers in the southern part of The Netherlands. Vet. Q. 21 50–54.

    Not in our library10.1080/01652176.1999.9694991

  26. 26.

    Esgleas M. Lacouture S. Gottschalk M. (2005 ). Streptococcus suis serotype 2 binding to extracellular matrix proteins. FEMS Microbiol. Lett. 244 33–40.

    Not in our library10.1016/j.femsle.2005.01.017

  27. 27.

    Fablet C. Marois C. Kuntz-Simon G. Rose N. Dorenlor V. Eono F. (2011 ). Longitudinal study of respiratory infection patterns of breeding sows in five farrow-to-finish herds. Vet. Microbiol. 147 329–339.

    Not in our library10.1016/j.vetmic.2010.07.005

  28. 28.

    Fablet C. Marois-Crehan C. Simon G. Grasland B. Jestin A. Kobisch M. (2012 ). Infectious agents associated with respiratory diseases in 125 farrow-to-finish pig herds: a cross-sectional study. Vet. Microbiol. 157 152–163.

    Not in our library10.1016/j.vetmic.2011.12.015

  29. 29.

    Feng W. Laster S. M. Tompkins M. Brown T. Xu J. S. Altier C. (2001 ). In utero infection by porcine reproductive and respiratory syndrome virus is sufficient to increase susceptibility of piglets to challenge by Streptococcus suis type II. J. Virol. 75 4889–4895.

    Not in our library10.1128/jvi.75.10.4889-4895.2001

  30. 30.

    Feng Y. Zhang H. Wu Z. Wang S. Cao M. Hu D. (2014 ). Streptococcus suis infection: an emerging/reemerging challenge of bacterial infectious diseases? Virulence 5 477–497.

    Not in our library10.4161/viru.28595

  31. 31.

    Fittipaldi N. Xu J. Lacouture S. Tharavichitkul P. Osaki M. Sekizaki T. (2011 ). Lineage and virulence of Streptococcus suis serotype 2 isolates from North America. Emerg. Infect. Dis. 17 2239–2244.

    Not in our library10.3201/eid1712.110609

  32. 32.

    Flores J. L. Higgins R. D’Allaire S. Charette R. Boudreau M. Gottschalk M. (1993 ). Distribution of the different capsular types of Streptococcus suis in nineteen swine nurseries. Can. Vet. J. 34 170–171.

    Not in our library

  33. 33.

    Fongcom A. Pruksakorn S. Mongkol R. Tharavichitkul P. Yoonim N. (2001 ). Streptococcus suis infection in northern Thailand. J. Med. Assoc. Thai. 84 1502–1508.

    Not in our library

  34. 34.

    Fulde M. Valentin-Weigand P. (2013 ). Epidemiology and pathogenicity of zoonotic streptococci. Curr. Top. Microbiol. Immunol. 368 49–81.

    Not in our library10.1007/82_2012_277

  35. 35.

    Gottschalk M. Lacouture S. Bonifait L. Roy D. Fittipaldi N. Grenier D. (2013 ). Characterization of Streptococcus suis isolates recovered between 2008 and 2011 from diseased pigs in Quebec, Canada. Vet. Microbiol. 162 819–825.

    Not in our library10.1016/j.vetmic.2012.10.028

  36. 36.

    Gottschalk M. Segura M. (2000 ). The pathogenesis of the meningitis caused by Streptococcus suis: the unresolved questions. Vet. Microbiol. 76 259–272.

    Not in our library10.1016/s0378-1135(00)00250-9

  37. 37.

    Gottschalk M. Xu J. Calzas C. Segura M. (2010 ). Streptococcus suis: a new emerging or an old neglected zoonotic pathogen? Future Microbiol. 5 371–391.

    Not in our library10.2217/fmb.10.2

  38. 38.

    Goyette-Desjardins G. Auger J. P. Xu J. Segura M. Gottschalk M. (2014 ). Streptococcus suis, an important pig pathogen and emerging zoonotic agent-an update on the worldwide distribution based on serotyping and sequence typing. Emerg. Microbes Infect. 3:e45.

    Not in our library10.1038/emi.2014.45

  39. 39.

    Grenier D. Grignon L. Gottschalk M. (2009 ). Characterisation of biofilm formation by a Streptococcus suis meningitis isolate. Vet. J. 179 292–295.

    Not in our library10.1016/j.tvjl.2007.09.005

  40. 40.

    Gustavsson C. Rasmussen M. (2014 ). Septic arthritis caused by Streptococcus suis serotype 5 in pig farmer. Emerg. Infect. Dis. 20 489–490.

    Not in our library10.3201/eid2003.130535

  41. 41.

    Haataja S. Tikkanen K. Hytonen J. Finne J. (1996 ). The Gal alpha 1-4 Gal-binding adhesin of Streptococcus suis, a gram-positive meningitis-associated bacterium. Adv. Exp. Med. Biol. 408 25–34.

    Not in our library10.1007/978-1-4613-0415-9_3

  42. 42.

    Haataja S. Tikkanen K. Liukkonen J. Francois-Gerard C. Finne J. (1993 ). Characterization of a novel bacterial adhesion specificity of Streptococcus suis recognizing blood group P receptor oligosaccharides. J. Biol. Chem. 268 4311–4317.

    Not in our library

  43. 43.

    Haataja S. Tikkanen K. Nilsson U. Magnusson G. Karlsson K. A. Finne J. (1994 ). Oligosaccharide-receptor interaction of the Gal alpha 1-4Gal binding adhesin of Streptococcus suis. Combining site architecture and characterization of two variant adhesin specificities. J. Biol. Chem. 269 27466–27472.

    Not in our library

  44. 44.

    Hajishengallis G. Lamont R. J. (2016 ). Dancing with the Stars: how choreographed bacterial interactions dictate nososymbiocity and give rise to keystone pathogens, accessory pathogens, and pathobionts. Trends Microbiol. 24 477–489.

    Not in our library10.1016/j.tim.2016.02.010

  45. 45.

    Han X. G. Lu C. P. (2009 ). Detection of autoinducer-2 and analysis of the profile of luxS and pfs transcription in Streptococcus suis serotype 2. Curr. Microbiol. 58 146–152.

    Not in our library10.1007/s00284-008-9291-9

  46. 46.

    Hatrongjit R. Kerdsin A. Gottschalk M. Takeuchi D. Hamada S. Oishi K. (2015 ). First human case report of sepsis due to infection with Streptococcus suis serotype 31 in Thailand. BMC Infect. Dis. 15:392.

    Not in our library10.1186/s12879-015-1136-0

  47. 47.

    Higgins R. Gottschalk M. Mittal K. R. Beaudoin M. (1990 ). Streptococcus suis infection in swine. A sixteen month study. Can. J. Vet. Res. 54 170–173.

    Not in our library

  48. 48.

    Hoa N. T. Chieu T. T. Do Dung S. Long N. T. Hieu T. Q. Luc N. T. (2013 ). Streptococcus suis and porcine reproductive and respiratory syndrome, Vietnam. Emerg. Infect. Dis. 19 331–333.

    Not in our library10.3201/eid1902.120470

  49. 49.

    Huang Y. T. Teng L. J. Ho S. W. Hsueh P. R. (2005 ). Streptococcus suis infection. J. Microbiol. Immunol. Infect. 38 306–313.

    Not in our library

  50. 50.

    Huong V. T. Hoa N. T. Horby P. Bryant J. E. Van Kinh N. Toan T. K. (2014 ). Raw pig blood consumption and potential risk for Streptococcus suis infection, Vietnam. Emerg. Infect. Dis. 20 1895–1898.

    Not in our library10.3201/eid2011.140915

  51. 51.

    Huong V. T. Thanh L. V. Phu V. D. Trinh D. T. Inui K. Tung N. (2016 ). Temporal and spatial association of Streptococcus suis infection in humans and porcine reproductive and respiratory syndrome outbreaks in pigs in northern Vietnam. Epidemiol. Infect. 144 35–44.

    Not in our library10.1017/s0950268815000990

  52. 52.

    Ip M. Fung K. S. Chi F. Cheuk E. S. Chau S. S. Wong B. W. (2007 ). Streptococcus suis in Hong Kong. Diagn. Microbiol. Infect. Dis. 57 15–20.

    Not in our library10.1016/j.diagmicrobio.2006.05.011

  53. 53.
    Genotypic Profile of Streptococcus suis Serotype 2 and Clinical Features of Infection in Humans, Thailand · 2011
    Not checked
  54. 54.

    Kerdsin A. Dejsirilert S. Sawanpanyalert P. Boonnark A. Noithachang W. Sriyakum D. (2011b ). Sepsis and spontaneous bacterial peritonitis in Thailand. Lancet 378:960

    Not in our library10.1016/s0140-6736(11)60923-9

  55. 55.
    Fatal Septic Meningitis in Child Caused by Streptococcus suis Serotype 24 · 2016
    Not checked
  56. 56.

    King S. J. Leigh J. A. Heath P. J. Luque I. Tarradas C. Dowson C. G. (2002 ). Development of a multilocus sequence typing scheme for the pig pathogen Streptococcus suis: identification of virulent clones and potential capsular serotype exchange. J. Clin. Microbiol. 40 3671–3680.

    Not in our library10.1128/jcm.40.10.3671-3680.2002

  57. 57.

    Krunkosky T. M. Jordan J. L. Chambers E. Krause D. C. (2007 ). Mycoplasma pneumoniae host-pathogen studies in an air-liquid culture of differentiated human airway epithelial cells. Microb. Pathog. 42 98–103.

    Not in our library10.1016/j.micpath.2006.11.003

  58. 58.

    Lachance C. Gottschalk M. Gerber P. P. Lemire P. Xu J. Segura M. (2013 ). Exacerbated type II interferon response drives hypervirulence and toxic shock by an emergent epidemic strain of Streptococcus suis. Infect. Immun. 81 1928–1939.

    Not in our library10.1128/iai.01317-12

  59. 59.

    Lalonde M. Segura M. Lacouture S. Gottschalk M. (2000 ). Interactions between Streptococcus suis serotype 2 and different epithelial cell lines. Microbiology 146 1913–1921.

    Not in our library10.1099/00221287-146-8-1913

  60. 60.

    Li W. Ye C. Jing H. Cui Z. Bai X. Jin D. (2010 ). Streptococcus suis outbreak investigation using multiple-locus variable tandem repeat number analysis. Microbiol. Immunol. 54 380–388.

    Not in our library10.1111/j.1348-0421.2010.00228.x

  61. 61.

    Lin X. Huang C. Shi J. Wang R. Sun X. Liu X. (2015 ). Investigation of pathogenesis of H1N1 influenza virus and swine Streptococcus suis serotype 2 co-infection in pigs by microarray analysis. PLoS One 10:e0124086.

    Not in our library10.1371/journal.pone.0124086

  62. 62.

    Loimaranta V. Jakubovics N. S. Hytönen J. Finne J. Jenkinson H. F. Strömberg N. (2005 ). Fluid- or surface-phase human salivary scavenger protein gp340 exposes different bacterial recognition properties. Infect. Immun. 73 2245–2252.

    Not in our library10.1128/iai.73.4.2245-2252.2005

  63. 63.

    Lowe B. A. Marsh T. L. Isaacs-Cosgrove N. Kirkwood R. N. Kiupel M. Mulks M. H. (2011 ). Microbial communities in the tonsils of healthy pigs. Vet. Microbiol. 147 346–357.

    Not in our library10.1016/j.vetmic.2010.06.025

  64. 64.

    Luque I. Blume V. Borge C. Vela A. I. Perea J. A. Marquez J. M. (2010 ). Genetic analysis of Streptococcus suis isolates recovered from diseased and healthy carrier pigs at different stages of production on a pig farm. Vet. J. 186 396–398.

    Not in our library10.1016/j.tvjl.2009.09.005

  65. 65.

    Ma E. Chung P. H. So T. Wong L. Choi K. M. Cheung D. T. (2008 ). Streptococcus suis infection in Hong Kong: an emerging infectious disease? Epidemiol. Infect. 136 1691–1697.

    Not in our library10.1017/s0950268808000332

  66. 66.

    MacInnes J. I. Gottschalk M. Lone A. G. Metcalf D. S. Ojha S. Rosendal T. (2008 ). Prevalence of Actinobacillus pleuropneumoniae, Actinobacillus suis, Haemophilus parasuis, Pasteurella multocida, and Streptococcus suis in representative Ontario swine herds. Can. J. Vet. Res. 72 242–248.

    Not in our library

  67. 67.

    Mai N. T. Hoa N. T. Nga T. V. Linh le D. Chau T. T. Sinh D. X. (2008 ). Streptococcus suis meningitis in adults in Vietnam. Clin. Infect. Dis. 46 659–667.

    Not in our library10.1086/527385

  68. 68.

    Marois C. Le Devendec L. Gottschalk M. Kobisch M. (2007 ). Detection and molecular typing of Streptococcus suis in tonsils from live pigs in France. Can. J. Vet. Res. 71 14–22.

    Not in our library

  69. 69.

    Meekhanon N. Kaewmongkol S. Phimpraphai W. Okura M. Osaki M. Sekizaki T. (2017 ). Potentially hazardous Streptococcus suis strains latent in asymptomatic pigs in a major swine production area of Thailand. J. Med. Microbiol. 66 662–669.

    Not in our library10.1099/jmm.0.000483

  70. 70.

    Meng F. Wu N. H. Nerlich A. Herrler G. Valentin-Weigand P. Seitz M. (2015 ). Dynamic Virus-bacterium interactions in a porcine precision-cut lung slice coinfection model: swine influenza virus paves the way for Streptococcus suis infection in a two-step process. Infect. Immun. 83 2806–2815.

    Not in our library10.1128/iai.00171-15

  71. 71.

    Meng F. Wu N. H. Seitz M. Herrler G. Valentin-Weigand P. (2016 ). Efficient suilysin-mediated invasion and apoptosis in porcine respiratory epithelial cells after streptococcal infection under air-liquid interface conditions. Sci. Rep. 6:26748.

    Not in our library10.1038/srep26748

  72. 72.

    Messier S. Lacouture S. Gottschalk M. Groupe de Recherche sur les Maladies Infectieusesdu Porc Centre de Recherche en Infectiologie Porcine (2008 ). Distribution of Streptococcus suis capsular types from 2001 to 2007. Can. Vet. J. 49 461–462.

    Not in our library

  73. 73.

    Morin J. P. Baste J. M. Gay A. Crochemore C. Corbiere C. Monteil C. (2013 ). Precision cut lung slices as an efficient tool for in vitro lung physio-pharmacotoxicology studies. Xenobiotica 43 63–72.

    Not in our library10.3109/00498254.2012.727043

  74. 74.

    Mothey D. Buttaro B. A. Piggot P. J. (2014 ). Mucin can enhance growth, biofilm formation, and survival of Streptococcus mutans. FEMS Microbiol. Lett. 350 161–167.

    Not in our library10.1111/1574-6968.12336

  75. 75.

    Muckle A. Giles J. Lund L. Stewart T. Gottschalk M. (2010 ). Isolation of Streptococcus suis from the urine of a clinically ill dog. Can. Vet. J. 51 773–774.

    Not in our library

  76. 76.

    Muckle A. Lopez A. Gottschalk M. Lopez-Mendez C. Giles J. Lund L. (2014 ). Isolation of Streptococcus suis from 2 lambs with a history of lameness. Can. Vet. J. 55 946–949.

    Not in our library

  77. 77.

    Nghia H. D. Hoa N. T. Linh le D. Campbell J. Diep T. S. Chau N. V. (2008 ). Human case of Streptococcus suis serotype 16 infection. Emerg. Infect. Dis. 14 155–157.

    Not in our library10.3201/eid1401.070534

  78. 78.

    Nghia H. D. Tu le T. P. Wolbers M. Thai C. Q. Hoang N. V. Nga T. V. (2011 ). Risk factors of Streptococcus suis infection in Vietnam. A case-control study. PLoS One 6:e17604.

    Not in our library10.1371/journal.pone.0017604

  79. 79.
    Current Taxonomical Situation of Streptococcus suis · 2016
    No notice
  80. 80.

    Okura M. Takamatsu D. Maruyama F. Nozawa T. Nakagawa I. Osaki M. (2013 ). Genetic analysis of capsular polysaccharide synthesis gene clusters from all serotypes of Streptococcus suis: potential mechanisms for generation of capsular variation. Appl. Environ. Microbiol. 79 2796–2806.

    Not in our library10.1128/aem.03742-12

  81. 81.

    Olson M. E. Ceri H. Morck D. W. Buret A. G. Read R. R. (2002 ). Biofilm bacteria: formation and comparative susceptibility to antibiotics. Can. J. Vet. Res. 66 86–92.

    Not in our library

  82. 82.

    Onishi H. Sugawara M. Okura M. Osaki M. Takamatsu D. (2012 ). Prevalence of Streptococcus suis genotypes in isolates from porcine endocarditis in East Japan. J. Vet. Med. Sci. 74 1681–1684.

    Not in our library10.1292/jvms.12-0301

  83. 83.

    Opriessnig T. Gimenez-Lirola L. G. Halbur P. G. (2011 ). Polymicrobial respiratory disease in pigs. Anim. Health Res. Rev. 12 133–148.

    Not in our library10.1017/s1466252311000120

  84. 84.

    Palermo L. M. Porotto M. Yokoyama C. C. Palmer S. G. Mungall B. A. Greengard O. (2009 ). Human parainfluenza virus infection of the airway epithelium: viral hemagglutinin-neuraminidase regulates fusion protein activation and modulates infectivity. J. Virol. 83 6900–6908.

    Not in our library10.1128/jvi.00475-09

  85. 85.

    Pian Y. Gan S. Wang S. Guo J. Wang P. Zheng Y. (2012 ). Fhb, a novel factor H-binding surface protein, contributes to the antiphagocytic ability and virulence of Streptococcus suis. Infect. Immun. 80 2402–2413.

    Not in our library10.1128/iai.06294-11

  86. 86.

    Power S. B. (1978 ). Streptococcus suis type 2 infection in pigs. Vet. Rec. 102 215–216.

    Not in our library10.1136/vr.102.10.215

  87. 87.

    Prince-David M. Salou M. Marois-Crehan C. Assogba K. Plainvert C. Balogou K. A. (2016 ). Human meningitis due to Streptococcus suis in Lome, Togo: a case report. BMC Infect. Dis. 16:651.

    Not in our library10.1186/s12879-016-2006-0

  88. 88.

    Prytherch Z. Job C. Marshall H. Oreffo V. Foster M. BeruBe K. (2011 ). Tissue-Specific stem cell differentiation in an in vitro airway model. Macromol. Biosci. 11 1467–1477.

    Not in our library10.1002/mabi.201100181

  89. 89.

    Robertson I. D. Blackmore D. K. (1989 ). Occupational exposure to Streptococcus suis type 2. Epidemiol. Infect. 103 157–164.

    Not in our library10.1017/s0950268800030454

  90. 90.

    Roy D. Grenier D. Segura M. Mathieu-Denoncourt A. Gottschalk M. (2016 ). Recruitment of factor H to the Streptococcus suis cell surface is multifactorial. Pathogens 5:E47.

    Not in our library10.3390/pathogens5030047

  91. 91.

    Salasia S. I. Lammler C. Herrmann G. (1995 ). Properties of a Streptococcus suis isolate of serotype 2 and two capsular mutants. Vet. Microbiol. 45 151–156.

    Not in our library10.1016/0378-1135(95)00036-a

  92. 92.

    Sanchez del Rey V. Fernandez-Garayzabal J. F. Briones V. Iriso A. Dominguez L. Gottschalk M. (2013 ). Genetic analysis of Streptococcus suis isolates from wild rabbits. Vet. Microbiol. 165 483–486.

    Not in our library10.1016/j.vetmic.2013.04.025

  93. 93.

    Sanchez del Rey V. Fernandez-Garayzabal J. F. Mentaberre G. Briones V. Lavin S. Dominguez L. (2014 ). Characterisation of Streptococcus suis isolates from wild boars (Sus scrofa). Vet. J. 200 464–467.

    Not in our library10.1016/j.tvjl.2014.03.013

  94. 94.

    Sanford S. E. Tilker M. E. (1982 ). Streptococcus suis type II-associated diseases in swine: observations of a one-year study. J. Am. Vet. Med. Assoc. 181 673–676.

    Not in our library

  95. 95.

    Schmitt C. S. Halbur P. G. Roth J. A. Kinyon J. M. Kasorndorkbua C. Thacker B. (2001 ). Influence of ampicillin, ceftiofur, attenuated live PRRSV vaccine, and reduced dose Streptococcus suis exposure on disease associated with PRRSV and S. suis coinfection. Vet. Microbiol. 78 29–37.

    Not in our library10.1016/s0378-1135(00)00289-3

  96. 96.

    Schultsz C. Jansen E. Keijzers W. Rothkamp A. Duim B. Wagenaar J. A. (2012 ). Differences in the population structure of invasive Streptococcus suis strains isolated from pigs and from humans in The Netherlands. PLoS One 7:e33854.

    Not in our library10.1371/journal.pone.0033854

  97. 97.

    Segura M. Calzas C. Grenier D. Gottschalk M. (2016 ). Initial steps of the pathogenesis of the infection caused by Streptococcus suis: fighting against nonspecific defenses. FEBS Lett. 590 3772–3799.

    Not in our library10.1002/1873-3468.12364

  98. 98.

    Segura M. Fittipaldi N. Calzas C. Gottschalk M. (2017 ). Critical Streptococcus suis virulence factors: are they all really critical? Trends Microbiol. 25 585–599.

    Not in our library10.1016/j.tim.2017.02.005

  99. 99.

    Segura M. Gottschalk M. Olivier M. (2004 ). Encapsulated Streptococcus suis inhibits activation of signaling pathways involved in phagocytosis. Infect. Immun. 72 5322–5330.

    Not in our library10.1128/iai.72.9.5322-5330.2004

  100. 100.

    Siqueira F. M. Perez-Wohlfeil E. Carvalho F. M. Trelles O. Schrank I. S. Vasconcelos A. T. R. (2017 ). Microbiome overview in swine lungs. PLoS One 12:e0181503.

    Not in our library10.1371/journal.pone.0181503

  101. 101.

    Smith H. E. Damman M. van der Velde J. Wagenaar F. Wisselink H. J. Stockhofe-Zurwieden N. (1999a ). Identification and characterization of the cps locus of Streptococcus suis serotype 2: the capsule protects against phagocytosis and is an important virulence factor. Infect. Immun. 67 1750–1756.

    Not in our library10.1128/iai.67.4.1750-1756.1999

  102. 102.

    Smith H. E. Veenbergen V. van der Velde J. Damman M. Wisselink H. J. Smits M. A. (1999b ). The cps genes of Streptococcus suis serotypes 1,2, and 9: development of rapid serotype-specific PCR assays. J. Clin. Microbiol. 37 3146–3152.

    Not in our library10.1128/jcm.37.10.3146-3152.1999

  103. 103.

    Smith T. C. Capuano A. W. Boese B. Myers K. P. Gray G. C. (2008 ). Exposure to Streptococcus suis among US swine workers. Emerg. Infect. Dis. 14 1925–1927.

    Not in our library10.3201/eid1412.080162

  104. 104.

    Staats J. J. Feder I. Okwumabua O. Chengappa M. M. (1997 ). Streptococcus suis: past and present. Vet. Res. Commun. 21 381–407.

    Not in our library10.1023/a:1005870317757

  105. 105.

    Strangmann E. Froleke H. Kohse K. P. (2002 ). Septic shock caused by Streptococcus suis: case report and investigation of a risk group. Int. J. Hyg. Environ. Health 205 385–392.

    Not in our library10.1078/1438-4639-00165

  106. 106.

    Takahashi Y. Konishi K. Cisar J. O. Yoshikawa M. (2002 ). Identification and characterization of hsa, the gene encoding the sialic acid-binding adhesin of Streptococcus gordonii DL1. Infect. Immun. 70 1209–1218.

    Not in our library10.1128/iai.70.3.1209-1218.2002

  107. 107.

    Takahashi Y. Sandberg A. L. Ruhl S. Muller J. Cisar J. O. (1997 ). A specific cell surface antigen of Streptococcus gordonii is associated with bacterial hemagglutination and adhesion to alpha2-3-linked sialic acid-containing receptors. Infect. Immun. 65 5042–5051.

    Not in our library10.1128/iai.65.12.5042-5051.1997

  108. 108.

    Takamatsu D. Nishino H. Ishiji T. Ishii J. Osaki M. Fittipaldi N. (2009 ). Genetic organization and preferential distribution of putative pilus gene clusters in Streptococcus suis. Vet. Microbiol. 138 132–139.

    Not in our library10.1016/j.vetmic.2009.02.013

  109. 109.

    Takamatsu D. Wongsawan K. Osaki M. Nishino H. Ishiji T. Tharavichitkul P. (2008 ). Streptococcus suis in humans, Thailand. Emerg. Infect. Dis. 14 181–183.

    Not in our library10.3201/eid1401.070568

  110. 110.

    Tanabe S. Bonifait L. Fittipaldi N. Grignon L. Gottschalk M. Grenier D. (2010 ). Pleiotropic effects of polysaccharide capsule loss on selected biological properties of Streptococcus suis. Can. J. Vet. Res. 74 65–70.

    Not in our library

  111. 111.
    Streptococcal Toxic Shock Syndrome Caused by Streptococcus suis Serotype 2 · 2006
    Corrected
  112. 112.

    Taniyama D. Sakurai M. Sakai T. Kikuchi T. Takahashi T. (2016 ). Human case of bacteremia due to Streptococcus suis serotype 5 in Japan: the first report and literature review. IDCases 6 36–38.

    Not in our library10.1016/j.idcr.2016.09.011

  113. 113.

    Tarradas C. Perea A. Vela A. I. Goyache J. Dominguez L. Fernandez-Garaizabal J. F. (2004 ). Distribution of serotypes of Streptococcus suis isolated from diseased pigs in Spain. Vet. Rec. 154 665–666.

    Not in our library10.1136/vr.154.21.665

  114. 114.

    Thanawongnuwech R. Brown G. B. Halbur P. G. Roth J. A. Royer R. L. Thacker B. J. (2000 ). Pathogenesis of porcine reproductive and respiratory syndrome virus-induced increase in susceptibility to Streptococcus suis infection. Vet. Pathol. 37 143–152.

    Not in our library10.1354/vp.37-2-143

  115. 115.

    Thongkamkoon P. Kiatyingangsulee T. Gottschalk M. (2017 ). Serotypes of Streptococcus suis isolated from healthy pigs in Phayao Province, Thailand. BMC Res Notes 10:53.

    Not in our library10.1186/s13104-016-2354-2

  116. 116.

    Tikkanen K. Haataja S. Finne J. (1996 ). The galactosyl-(alpha 1-4)-galactose-binding adhesin of Streptococcus suis: occurrence in strains of different hemagglutination activities and induction of opsonic antibodies. Infect. Immun. 64 3659–3665.

    Not in our library10.1128/iai.64.9.3659-3665.1996

  117. 117.

    Tikkanen K. Haataja S. Francois-Gerard C. Finne J. (1995 ). Purification of a galactosyl-alpha 1-4-galactose-binding adhesin from the gram-positive meningitis-associated bacterium Streptococcus suis. J. Biol. Chem. 270 28874–28878.

    Not in our library10.1074/jbc.270.48.28874

  118. 118.

    Urwin R. Maiden M. C. (2003 ). Multi-locus sequence typing: a tool for global epidemiology. Trends Microbiol. 11 479–487.

    Not in our library10.1016/j.tim.2003.08.006

  119. 119.

    Vela A. I. Goyache J. Tarradas C. Luque I. Mateos A. Moreno M. A. (2003 ). Analysis of genetic diversity of Streptococcus suis clinical isolates from pigs in Spain by pulsed-field gel electrophoresis. J. Clin. Microbiol. 41 2498–2502.

    Not in our library10.1128/jcm.41.6.2498-2502.2003

  120. 120.

    Vendeville A. Winzer K. Heurlier K. Tang C. M. Hardie K. R. (2005 ). Making ’sense’ of metabolism: autoinducer-2, LuxS and pathogenic bacteria. Nat. Rev. Microbiol. 3 383–396.

    Not in our library10.1038/nrmicro1146

  121. 121.

    Wang K. Lu C. (2008 ). Streptococcus suis type 2 culture supernatant enhances the infection ability of the Swine influenza virus H3 subtype in MDCK cells. Berl. Munch. Tierarztl. Wochenschr. 121 198–202.

    Not in our library

  122. 122.

    Wang K. Zhang W. Li X. Lu C. Chen J. Fan W. (2013a ). Characterization of Streptococcus suis isolates from slaughter swine. Curr. Microbiol. 66 344–349.

    Not in our library10.1007/s00284-012-0275-4

  123. 123.

    Wang Y. Yi L. Zhang Z. Fan H. Cheng X. Lu C. (2013c ). Overexpression of luxS cannot increase autoinducer-2 production, only affect the growth and biofilm formation in Streptococcus suis. Sci. World J. 2013:924276.

    Not in our library10.1155/2013/924276

  124. 124.

    Wang Y. Gagnon C. A. Savard C. Music N. Srednik M. Segura M. (2013b ). Capsular sialic acid of Streptococcus suis serotype 2 binds to swine influenza virus and enhances bacterial interactions with virus-infected tracheal epithelial cells. Infect. Immun. 81 4498–4508.

    Not in our library10.1128/iai.00818-13

  125. 125.
    Crystal Structure and Identification of Two Key Amino Acids Involved in AI-2 Production and Biofilm Formation in Streptococcus suis LuxS. · 2015
    Not checked
  126. 126.

    Wang Y. Zhang W. Wu Z. Lu C. (2011a ). Reduced virulence is an important characteristic of biofilm infection of Streptococcus suis. FEMS Microbiol. Lett. 316 36–43.

    Not in our library10.1111/j.1574-6968.2010.02189.x

  127. 127.

    Wang Y. Zhang W. Wu Z. Zhu X. Lu C. (2011b ). Functional analysis of luxS in Streptococcus suis reveals a key role in biofilm formation and virulence. Vet. Microbiol. 152 151–160.

    Not in our library10.1016/j.vetmic.2011.04.029

  128. 128.

    Wertheim H. F. Nghia H. D. Taylor W. Schultsz C. (2009 ). Streptococcus suis: an emerging human pathogen. Clin. Infect. Dis. 48 617–625.

    Not in our library10.1086/596763

  129. 129.

    Whitsett J. A. Alenghat T. (2015 ). Respiratory epithelial cells orchestrate pulmonary innate immunity. Nat. Immunol. 16 27–35.

    Not in our library10.1038/ni.3045

  130. 130.

    Willenborg J. Fulde M. de Greeff A. Rohde M. Smith H. E. Valentin-Weigand P. (2011 ). Role of glucose and CcpA in capsule expression and virulence of Streptococcus suis. Microbiology 157 1823–1833.

    Not in our library10.1099/mic.0.046417-0

  131. 131.

    Wisselink H. J. Smith H. E. Stockhofe-Zurwieden N. Peperkamp K. Vecht U. (2000 ). Distribution of capsular types and production of muramidase-released protein (MRP) and extracellular factor (EF) of Streptococcus suis strains isolated from diseased pigs in seven European countries. Vet. Microbiol. 74 237–248.

    Not in our library10.1016/s0378-1135(00)00188-7

  132. 132.

    Wongsawan K. Gottschalk M. Tharavichitkul P. (2015 ). Serotype- and virulence-associated gene profile of Streptococcus suis isolates from pig carcasses in Chiang Mai Province, Northern Thailand. J. Vet. Med. Sci. 77 233–236.

    Not in our library10.1292/jvms.14-0380

  133. 133.

    Wu N. H. Meng F. Seitz M. Valentin-Weigand P. Herrler G. (2015 ). Sialic acid-dependent interactions between influenza viruses and Streptococcus suis affect the infection of porcine tracheal cells. J. Gen. Virol. 96 2557–2568.

    Not in our library10.1099/jgv.0.000223

  134. 134.

    Xiao G. Tang H. Zhang S. Ren H. Dai J. Lai L. (2017 ). Streptococcus suis small RNA rss04 contributes to the induction of meningitis by regulating capsule synthesis and by inducing biofilm formation in a mouse infection model. Vet. Microbiol. 199 111–119.

    Not in our library10.1016/j.vetmic.2016.12.034

  135. 135.
    Streptococcus suis Sequence Type 7 Outbreak, Sichuan, China · 2006
    No notice
  136. 136.
    Human Streptococcus suis Outbreak, Sichuan, China · 2006
    No notice
  137. 137.

    Zhang C. Hao H. Yu Y. Kong D. Chen S. Jiang H. (2016 ). Structural basis of the interaction between the meningitis pathogen Streptococcus suis adhesin Fhb and its human receptor. FEBS Lett. 590 1384–1392.

    Not in our library10.1002/1873-3468.12174

  138. 138.

    Zhu J. Miller M. B. Vance R. E. Dziejman M. Bassler B. L. Mekalanos J. J. (2002 ). Quorum-sensing regulators control virulence gene expression in Vibrio cholerae. Proc. Natl. Acad. Sci. U.S.A. 99 3129–3134.

    Not in our library10.1073/pnas.052694299

  139. 139.

    Zhu W. Wu C. Sun X. Zhang A. Zhu J. Hua Y. (2013 ). Characterization of Streptococcus suis serotype 2 isolates from China. Vet. Microbiol. 166 527–534.

    Not in our library10.1016/j.vetmic.2013.06.009

Cited by papers we hold 4

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.